Target intelligence / Profile preview

Armadillo repeat-containing protein 9 (ARMC9)

Target
ARMC9
Molecular classification
Other (contains LisH domain, armadillo repeats, coiled-coil domains)
01

Overview

Armadillo repeat-containing protein 9 (ARMC9) is a cytoplasmic protein localized to the basal body and centrosome of primary cilia and contains LisH (lissencephaly type-1-like homology) and armadillo repeat domains[1][3]. It is required for proper cilium formation (ciliogenesis), ciliary microtubule modification, and positive regulation of Hedgehog signaling, likely through regulation of GLI2/GLI3 trafficking at the ciliary tip[3]. ARMC9 is crucial for vertebrate brain development; mutations in ARMC9 cause Joubert syndrome 30, a rare neurodevelopmental disorder featuring cerebellar hypoplasia, hypotonia, and abnormal eye movements[1][3]. It forms complexes with other basal body/ciliary proteins including TOGARAM1, CSPP1, CCDC66, and CEP290, suggesting a role as a scaffolding or organizing molecule for ciliary protein modules[4]. Evidence also implicates ARMC9 in modulating the cell cycle and nuclear protein localization[2]. There is currently no evidence that ARMC9 is a direct therapeutic target or that drugs are known to target it for disease treatment.

Other names
LisH domain-containing protein ARMC9KIAA1868FLJ12584KU-MEL-1Melanoma/melanocyte-specific tumor antigen KU-MEL-1NS21JBTS30ARMArmadillo repeat containing 9
02

Biological functions

Cilium assemblyCiliogenesisRegulation of cilium lengthPositive regulation of Hedgehog signaling pathwayCell cycle regulationNuclear protein transport
03

Disease associations

Neurodevelopmental disorders (notably Joubert syndrome 30)

Beyond the preview

Go deeper on Armadillo repeat-containing protein 9 (ARMC9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Armadillo repeat-containing protein 9 (ARMC9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call